Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Utah Medical Products

This article was originally published in The Gray Sheet

Executive Summary

Will begin shipments of its Toco Bubble in approximately one month. The dynamometer device is designed to measure uterine contraction during labor and delivery. The firm began taking orders for the device immediately after receiving FDA 510(k) clearance for the product on June 4. The company says the Toco Bubble, which is several inches in diameter and adheres directly to the abdomen, is intended to replace belt devices that currently are used to measure uterine contractions. The device is disposable and sells for $5 to hospitals. The firm sells connector tubing and a reusable adaptor designed to connect the device to a monitor separately. On June 15, Utah announced that it no longer is under investigation by the Securities and Exchange Commission. Records subpoenaed in 1992 by the Department of Justice, Utah district, recently were returned to the company. Although it never was informed of the reasons for the investigation, the company says it may have been in connection with the indictment of former president and CEO William Dean Wallace on charges that included insider trading and falsification of firm records. Wallace was acquitted in December 1992 ("The Gray Sheet" Jan. 4, In Brief).

You may also be interested in...

QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.

Novartis Logs Into India With Digital Innovation Hub

Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.

Rx List Price Inflation Penalty Endorsed By US HHS Secretary

Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts